Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Sep 16;15(18):4862-72.

Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage

Affiliations

Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage

R W Hendriks et al. EMBO J. .

Abstract

Bruton's tyrosine kinase (Btk) is a cytoplasmic protein kinase that is defective in X-linked agammaglobulinaemia in man and in X-linked immunodeficiency in the mouse. There is controversy regarding the stages of B cell development that are dependent on Btk function. To determine the point in B cell differentiation at which defects in Btk become apparent, we generated a mouse model by inactivating the Btk gene through an in-frame insertion of a lacZ reporter by homologous recombination in embryonic stem cells. The phenomenon of X-chromosome inactivation in Btk+/- heterozygous female mice enabled us to evaluate the competition between B cell progenitors expressing wild-type Btk and those expressing the Btk-/lacZ allele in each successive step of development. Although Btk was already expressed in pro-B cells, the first selective disadvantage only became apparent at the transition from small pre-B cells to immature B cells in the bone marrow. A second differentiation arrest was found during the maturation from IgD(low)IgM(high) to IgD(high)IgM(low) stages in the periphery. Our results show that Btk expression is essential at two distinct differentiation steps, both past the pre-B cell stage.

PubMed Disclaimer

References

    1. J Exp Med. 1993 Sep 1;178(3):951-60 - PubMed
    1. Pediatrics. 1952 Jun;9(6):722-8 - PubMed
    1. Int Immunol. 1993 Sep;5(9):1093-8 - PubMed
    1. J Immunol. 1994 Jan 15;152(2):557-65 - PubMed
    1. Leukemia. 1994 Apr;8(4):574-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources